neb: a zebrafish model of nemaline myopathy due to nebulin mutation

WR Telfer, DD Nelson, T Waugh… - Disease models & …, 2012 - journals.biologists.com
WR Telfer, DD Nelson, T Waugh, SV Brooks, JJ Dowling
Disease models & mechanisms, 2012journals.biologists.com
Nemaline myopathy is one of the most common and severe non-dystrophic muscle diseases
of childhood. Patients typically present in infancy with hypotonia, weakness, delayed motor
development, and bulbar and respiratory difficulties. Mutations in six different genes are
associated with nemaline myopathy, with nebulin mutations being the most common. No
treatments or disease-modifying therapies have been identified for this disease. One of the
major barriers to treatment development is the lack of models amenable to rapid and …
Summary
Nemaline myopathy is one of the most common and severe non-dystrophic muscle diseases of childhood. Patients typically present in infancy with hypotonia, weakness, delayed motor development, and bulbar and respiratory difficulties. Mutations in six different genes are associated with nemaline myopathy, with nebulin mutations being the most common. No treatments or disease-modifying therapies have been identified for this disease. One of the major barriers to treatment development is the lack of models amenable to rapid and coordinated testing of potential therapeutic strategies. To overcome this barrier, we have characterized the first zebrafish model of nemaline myopathy. This model, termed neb, harbors a recessive mutation in the nebulin gene that results in decreased Nebulin protein levels, a severe motor phenotype and premature lethality. In addition to impaired motor function, neb zebrafish exhibit many of the features associated with human nemaline myopathy. These include impaired force generation, altered thin filament length and the presence of specific histopathological changes, including the formation of nemaline bodies. In summary, neb zebrafish mirror the genetic, clinical and pathological aspects of nemaline myopathy due to NEB mutation, and thus are an excellent model for future therapy development for this devastating disorder.
journals.biologists.com